Plans to restrict the number of formal ADHD diagnoses within the NHS have sparked a fierce backlash from campaigners who claim the move amounts to rationing basic healthcare. A government review led by Professor Peter Fonagy is expected to suggest a shift toward a triage system where patients are offered support based on their immediate needs rather than an automatic path to a formal diagnosis. Under this proposal, official assessments would be reserved for those most acutely affected, such as individuals at risk of self harm or those completely unable to work, while others would receive holistic assistance tailored to their specific struggles in school or employment.
The initiative comes as the government grapples with a massive surge in demand, with roughly 800,000 people currently languishing on NHS waiting lists. Officials expressed concern over the rising number of sickness benefit claims linked to neurodiversity and mental health conditions. By decoupling support from diagnosis, the review argues that children and adults could receive targeted help, such as classroom adjustments or flexible working hours, without having to wait years for a clinician’s sign off. This approach is likely to be extended beyond ADHD to encompass autism and broader mental health services across the board.
However, advocacy groups argue that there is no such thing as mild ADHD and that denying a formal label strips patients of their identity and legal protections. Henry Shelford, chief executive of ADHD UK, warned that these measures effectively disappear people from waiting lists rather than treating them. He cautioned that without professional confirmation, vulnerable individuals will increasingly turn to social media platforms like TikTok for self diagnosis, leaving schools and employers to rely on unreliable internet trends rather than clinical evidence when deciding how to provide support.
Critics also highlighted the severe long term risks associated with untreated ADHD, citing statistics that show significantly lower life expectancies for both men and women with the condition. While some mental health experts agree that effective help can sometimes be delivered without a label, many insist that a diagnosis is often the catalyst for people turning their lives around and returning to the workforce. Campaigners pointed out the irony of spending hundreds of millions on weight loss drugs while restricting affordable medications for ADHD, arguing that investing in proper diagnostics provides a far higher return for the economy and public health.
